AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitaclass M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitaclass M 50/1000 Tablet

Diabetic patients with type 2 mellitus may be prescribed the dual-action Sitaclass M 50/1000 Tablet to manage elevated blood glucose. This medication helps mitigate severe diabetic complications, such as renal impairment and vision loss, and may lessen the risk of cardiovascular events. Sitaclass M 50/1000 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal efficacy is achieved with a balanced diet and regular physical activity. Dosage is individualized, considering patient health, glycemic control, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management. Commonly reported adverse effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia, a potential side effect, particularly when used with insulin or sulfonylureas, requires appropriate recognition and management strategies. Prior to commencing treatment, inform your physician of any existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before initiating therapy. Potential drug interactions necessitate a comprehensive medication review with your doctor to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effect. Regular monitoring of renal function and blood glucose levels is integral throughout treatment.

Uses of Sitaclass M 50/1000 Tablet

Managing type 2 diabetes

Major Benefits of Sitaclass M 50/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaclass M 50/1000 with a meal.

Common Side effects of Sitaclass M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitaclass M 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitaclass M 50/1000 Tablet with a meal.

How Sitaclass M 50/1000 Tablet works:

Sitagliptin and metformin, combined as Sitaclass M 50/1000 Tablet, work synergistically to manage blood glucose. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin responsiveness. This dual action results in superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitaclass M 50/1000 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitaclass M 50/1000 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitaclass M 50/1000 tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitaclass M 50/1000 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitaclass M 50/1000 Tablets. Physician consultation is essential. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitaclass M 50/1000 Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitaclass M 50/1000 Tablet :

Should you forget a Sitaclass M 50/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitaclass M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitaclass M 50/1000 Tablet

Sitaclass M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitaclass M 50/1000 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitaclass M 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitaclass M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaclass M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitaclass M 50/1000) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitaclass M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaclass M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Sitaclass M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaclass M 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/metformin (Sitaclass M 50/1000) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/metformin and seek immediate medical attention.
Prolonged Sitaclass M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitaclass M 50/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitaclass M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Sitaclass M 50/1000 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitaclass M 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitaclass M 50/1000) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged Sitaclass M 50/1000 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitaclass M 50/1000 Table...
99
MRP 115
13% off